Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
Congratulations to our colleagues at Cambridge Consultants, who today announced their role in the development of the first fully at-home, prescription-free COVID-19 test to receive U.S. Government Emergency Use Authorization.
